Rothschild & Co Asset Management US’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $6.46M | Buy |
|
|||||
|
2022
Q3 | $5M | Buy |
|
|||||
|
2022
Q2 | $2.93M | Buy |
|
|||||
|
2022
Q1 | $3.19M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $9.83M | Sell |
|
|||||
|
2020
Q1 | $6.3M | Sell |
|
|||||
|
2019
Q4 | $6.8M | Buy |
|
|||||
|
2019
Q3 | $4.6M | Buy |
|
|||||
|
2019
Q2 | $6.68M | Buy |
|
|||||
|
2019
Q1 | $3.85M | Buy |
|
|||||
|
2018
Q4 | $1.25M | Sell |
|
|||||
|
2018
Q3 | $2.21M | Sell |
|
|||||
|
2018
Q2 | $2.25M | Buy |
|
|||||
|
2018
Q1 | $1.19M | Sell |
|
|||||
|
2017
Q4 | $1.17M | Sell |
|
|||||
|
2017
Q3 | $1.44M | Sell |
|
|||||
|
2017
Q2 | $1.7M | Sell |
|
|||||
|
2017
Q1 | $1.96M | Sell |
|
|||||
|
2016
Q4 | $2.18M | Buy |
|
|||||
|
2016
Q3 | $397K | Buy |
|
|||||
|
2016
Q2 | $233K | Buy |
|